2-METHYL-N-(8-(METHYLAMINO)-5-(6-(4-MORPHOLINYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)PYRIDO(3,4-C)PYRIDAZIN-3-YL)-CYCLOPROPANECARBOXAMIDE,, (1S,2R)-
UNII XNJ98N4L95

Substance Identification & Data

This profile provides standardized clinical and technical data for 2-methyl-n-(8-(methylamino)-5-(6-(4-morpholinyl)(1,2,4)triazolo(1,5-a)pyridin-2-yl)pyrido(3,4-c)pyridazin-3-yl)-cyclopropanecarboxamide,, (1s,2r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XNJ98N4L95.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3116918-57-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XNJ98N4L95

CAS Registry Number

3116918-57-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

2-METHYL-N-(8-(METHYLAMINO)-5-(6-(4-MORPHOLINYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)PYRIDO(3,4-C)PYRIDAZIN-3-YL)-CYCLOPROPANECARBOXAMIDE,, (1S,2R)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H25N9O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MDAVNUVUWHAZFH-HIFRSBDPSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

178122947

Unique identification number in the NCBI database of chemical substances.

Substance Type

2-methyl-N-[8-(methylamino)-5-[6-(4-morpholinyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]pyrido[3,4-c]pyridazin-3-yl]-Cyclopropanecarboxamide,, (1S,2R)-

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(C)c1c2c(c(cn1)-c3nn4c(n3)ccc(c4)N5CCOCC5)cc(NC(=O)[C@@H]6[C@H](C)C6)nn2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 2-methyl-n-(8-(methylamino)-5-(6-(4-morpholinyl)(1,2,4)triazolo(1,5-a)pyridin-2-yl)pyrido(3,4-c)pyridazin-3-yl)-cyclopropanecarboxamide,, (1s,2r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.